Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 23, 2017

DrugPatentWatch Database Preview

Cyclosporine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cyclosporine and what is the scope of freedom to operate?

Cyclosporine
is the generic ingredient in six branded drugs marketed by Abbvie, West-ward Pharms Int, Ivax Sub Teva Pharms, Novartis, Sandoz, Wockhardt, Apotex, Mayne Pharma, Luitpold, Apotex Inc, and Allergan, and is included in eighteen NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Cyclosporine has one patent family member in one country.

There are seventeen drug master file entries for cyclosporine. Fifteen suppliers are listed for this compound.

Summary for Generic Name: cyclosporine

Tradenames:6
Patents:7
Applicants:11
NDAs:18
Drug Master File Entries: see list17
Suppliers / Packagers: see list15
Bulk Api Vendors: see list105
Clinical Trials: see list325
Patent Applications: see list9,911
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:cyclosporine at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis
SANDIMMUNE
cyclosporine
SOLUTION;ORAL050574-001Nov 14, 1983AB2RXYesYes► Subscribe► Subscribe
Novartis
NEORAL
cyclosporine
CAPSULE;ORAL050715-003Jul 14, 1995DISCNYesNo► Subscribe► Subscribe
Novartis
SANDIMMUNE
cyclosporine
CAPSULE;ORAL050625-001Mar 2, 1990AB2RXYesNo► Subscribe► Subscribe
Luitpold
CYCLOSPORINE
cyclosporine
INJECTABLE;INJECTION065151-001Oct 7, 2003APRXNoNo► Subscribe► Subscribe
Allergan
RESTASIS MULTIDOSE
cyclosporine
EMULSION;OPHTHALMIC050790-002Oct 27, 2016RXYesYes8,642,556► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot